Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Revenue

Intech Biopharm had revenue of 87.77M TWD in the quarter ending June 30, 2025, with 1,585.56% growth. This brings the company's revenue in the last twelve months to 115.23M, up 256.99% year-over-year. In the year 2024, Intech Biopharm had annual revenue of 39.78M with 53.90% growth.

• Revenue (ttm): 115.23M
• Revenue Growth: +256.99%
• P/S Ratio: 22.55
• Revenue / Employee: 1.28M
• Employees: 90
• Market Cap: 2.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.78M	13.93M	53.90%
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%
Dec 31, 2020	21.11M	4.42M	26.50%